Skip to main content

Hawkins James B's Form 4 filing

Iradimed Corp (IRMD) · filed Dec 5, 2023

Accession no.
0001415889-23-015865
Filed
Dec 5, 2023
Trade date
Dec 1-4, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $410.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hawkins James BCIK 0000898243Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 1, 2023Common StockAGrant or awardAcquired+5,259$7.10F1+$37,338.941,821Direct
Dec 1, 2023Common StockSSaleDisposed−5,259$43.28F2−$227,609.5236,562Direct
Dec 4, 2023Common StockAGrant or awardAcquired+4,273$7.10F1+$30,338.340,835Direct
Dec 4, 2023Common StockSSaleDisposed−4,273$42.70F3−$182,457.136,562Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 1, 2023Common StockMOption exerciseDisposed−5,259$0.00$04,741Direct
Dec 4, 2023Common StockMOption exerciseDisposed−4,273$0.00$0468Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This option, representing a right to purchase a total of 10,000 shares, was granted on 9-29-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Referenced by the price of 2 transactions in Table I.

F2

This transaction was executed in multiple trades at prices ranging from $42.70 to $43.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $42.70 to $42.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)